Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3

Platelets

Volumn 27, Issue 6, 2016, Pages 535-540

  Watson, Callum N ^a   Kerrigan, Steven W ^b   Cox, Dermot ^b   Henderson, Ian R ^a   Watson, Steve P ^a   Arman, Mònica ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Blood platelets; Escherichia coli; Fc gamma receptor IIA; immunity; thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; FC RECEPTOR IIA; IMMUNOGLOBULIN G; INTEGRIN; INTEGRIN ALPHA2B BETA3; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; THROMBOXANE A2; UNCLASSIFIED DRUG; FC RECEPTOR; FIBRINOGEN RECEPTOR; PROTEIN BINDING;

ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LIGHT TRANSMISSION AGGREGOMETRY; MOLECULAR INTERACTION; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; URINARY TRACT INFECTION; BLOOD CLOTTING PARAMETERS; IMMUNOLOGY; METABOLISM; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; ESCHERICHIA COLI; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; RECEPTORS, IGG; SRC-FAMILY KINASES; SYK KINASE; THROMBOXANE A2;

EID: 84961886554     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2016.1148129     Document Type: Article

References (38)

1. D.Cox, S.W.Kerrigan, S.P.Watson Platelets and the innate immune system:mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011;9:1097–1107.
2. B.Engelmann, S.Massberg Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34–45.
3. G.J.Seymour, P.J.Ford, M.P.Cullinan, S.Leishman, M.J.West, K.Yamazaki Infection or inflammation:the link between periodontal and cardiovascular diseases. Future Cardiol 2009;5:5–9.
4. C.R.Meier, L.E.Derby, S.S.Jick, C.Vasilakis, H.Jick Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 1999;281:427–431.
5. Y.A.Que, P.Moreillon Infective endocarditis. Nat Rev Cardiol 2011;8:322–336.
6. S.W.Kerrigan The expanding field of platelet-bacterial interconnections. Platelets 2015;26:293–301.
7. O.Shannon, E.Hertzen, A.Norrby-Teglund, M.Morgelin, U.Sjobring, L.Bjorck Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 2007;65:1147–1157.
8. D.Tilley, M.Arman, A.Smolenski, D.Cox, J.O’Donnell, C.Douglas, S.Watson, K.S.Glycoprotein IbalphaKerrigan S. and FcgammaRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost 2013;11:941–950.
9. C.Keane, D.Tilley, A.Cunningham, A.Smolenski, A.Kadioglu, D.Cox, H.F.Jenkinson, S.W.Kerrigan Invasive Streptococcus pneumoniae trigger platelet activation via Toll-like receptor 2. J Thromb Haemost 2010;8:2757–2765.
10. C.Keane, H.Petersen, K.Reynolds, D.K.Newman, D.Cox, H.F.Jenkinson, P.J.Newman, S.W.Kerrigan Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. Arterioscler Thromb Vasc Biol 2010;30:2408–2415.
11. S.W.Kerrigan, I.Douglas, A.Wray, J.Heath, M.F.Byrne, D.Fitzgerald, D.Cox A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002;100:509–516.
12. S.W.Kerrigan, N.Clarke, A.Loughman, G.Meade, T.J.Foster, D.Cox Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol 2008;28:335–340.
13. C.Pampolina, A.McNicol Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. Thromb Haemost 2005;93:932–939.
14. M.Arman, K.Krauel, D.O.Tilley, C.Weber, D.Cox, A.Greinacher, S.W.Kerrigan, S.P.Watson Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood 2014;123:3166–3174.
15. M.Arman, K.Krauel Human platelet IgG Fc receptor FcgammaRIIA in immunity and thrombosis. J Thromb Haemost 2015;13:893–908.
16. D.G.Brooks, W.Q.Qiu, A.D.Luster, J.V.Ravetch Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 1989;170:1369–1385.
17. J.B.Kaper, J.P.Nataro, H.L.Mobley Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2:123–140.
18. G.S.Martin, D.M.Mannino, S.Eaton, M.Moss The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–1554.
19. M.E.de Kraker, V.Jarlier, J.C.Monen, O.E.Heuer, N.van de Sande, H.Grundmann The changing epidemiology of bacteraemias in Europe:trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 2013;19:860–868.
20. D.McPherson, C.Griffiths, M.Williams, A.Baker, E.Klodawski, B.Jacobson, L.Donaldson Sepsis-associated mortality in England:an analysis of multiple cause of death data from 2001 to 2010. BMJ Open 2013;3:e002586. doi:10.1136/bmjopen-2013-002586.
21. C.C.Clawson, J.G.White Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol 1971;65:367–380.
22. H.L.Mobley, D.M.Green, A.L.Trifillis, D.E.Johnson, G.R.Chippendale, C.V.Lockatell, B.D.Jones, J.W.Warren Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells:role of hemolysin in some strains. Infect Immun 1990;58:1281–1289.
23. R.P.Silver, W.Aaronson, A.Sutton, R.Schneerson Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect Immun 1980;29:200–206.
24. J.R.Fitzgerald, T.J.Foster, D.Cox The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006;4:445–457.
25. A.Loughman, J.R.Fitzgerald, M.P.Brennan, J.Higgins, R.Downer, D.Cox, T.J.Foster Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005;57:804–818.
26. H.Miajlovic, A.Loughman, M.Brennan, D.Cox, T.J.Foster Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. Infect Immun 2007;75:3335–3343.
27. H.J.Petersen, C.Keane, H.F.Jenkinson, M.M.Vickerman, A.Jesionowski, J.C.Waterhouse, D.Cox, S.W.Kerrigan Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun 2010;78:413–422.
28. B.Boylan, C.Gao, V.Rathore, J.C.Gill, D.K.Newman, P.J.Newman Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood 2008;112:2780–2786.
29. H.Zhi, L.Rauova, V.Hayes, C.Gao, B.Boylan, D.K.Newman, S.E.McKenzie, B.C.Cooley, M.Poncz, P.J.Newman Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood 2012;121:1858–1867.
30. M.F.Byrne, S.W.Kerrigan, P.A.Corcoran, J.C.Atherton, F.E.Murray, D.J.Fitzgerald, D.M.Cox Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003;124:1846–1854.
31. M.Naito, E.Sakai, Y.Shi, H.Ideguchi, M.Shoji, N.Ohara, K.Yamamoto, K.Nakayama Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase. Mol Microbiol 2006;59:152–167.
32. I.Ford, C.W.Douglas, D.Cox, D.G.Rees, J.Heath, F.E.Preston The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol 1997;97:737–746.
33. A.McNicol, R.Zhu, R.Pesun, C.Pampolina, E.C.Jackson, G.H.Bowden, T.Zelinski A role for immunoglobulin G in donor-specific Streptococcus sanguis-induced platelet aggregation. Thromb Haemost 2006;95:288–293.
34. S.Johnson, A.Waters Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome? Immunobiology 2012;217:235–243.
35. D.Karpman, D.Papadopoulou, K.Nilsson, A.C.Sjogren, C.Mikaelsson, S.Lethagen Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 2001;97:3100–3108.
36. A.L.Stahl, M.Svensson, M.Morgelin, C.Svanborg, P.I.Tarr, J.C.Mooney, S.L.Watkins, R.Johnson, D.Karpman Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 2006;108:167–176.
37. J.Berthet, P.Damien, H.Hamzeh-Cognasse, C.A.Arthaud, M.A.Eyraud, F.Zeni, B.Pozzetto, A.McNicol, O.Garraud, F.Cognasse Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol 2012;145:189–200.
38. A.H.Riaz, B.E.Tasma, M.E.Woodman, R.M.Wooten, R.G.Worth Human platelets efficiently kill IgG-opsonized E. coli. FEMS Immunol Med Microbiol 2012;65:78–83.